# Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis

> **NCT02335580** · — · COMPLETED · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 475 (actual)

## Conditions studied

- Liver Cirrhosis
- Portal Vein
- Venous Thrombosis
- Varicose Veins
- Hemorrhage

## Interventions

- **DRUG:** Somatostatin and its analogs
- **PROCEDURE:** Endoscopic sclerotherapy, endoscopic variceal ligation, endoscopic tissue glue injection

## Key facts

- **NCT ID:** NCT02335580
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 475 (ACTUAL)
- **Last updated:** 2023-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02335580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02335580, "Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02335580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*